GlassScriptPhysician profile
Jacob Ornelas
NPI 1972766715
$750.14
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.43 · 2020: $14.77 · 2021: $107 · 2022: $298 · 2023: $189 · 2024: $42.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $231.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $100.45 | 2023 | Myfembree |
| Intuitive Surgical, INC. | $98.71 | 2022 | |
| Myovant Sciences INC. | $81.96 | 2022 | |
| Mayne Pharma Commercial LLC | $66.29 | 2021 | |
| Daiichi Sankyo INC. | $64.08 | 2022 | |
| Coopersurgical, INC. | $57.01 | 2021-2022 | |
| Innovation Technologies INC | $39.49 | 2023 | Irrisept |
| Amgen INC. | $37.26 | 2019-2024 | Prolia, Evenity |
| Merck Sharp & Dohme LLC | $30.00 | 2019 | |
| Abbvie INC. | $27.53 | 2020-2022 | |
| Northgate Technologies, INC. | $24.56 | 2022 | |
| Pfizer INC. | $22.37 | 2023 | |
| Allergan, INC. | $19.13 | 2019 | |
| Sanofi Pasteur INC. | $19.11 | 2019 | |
| Organon LLC | $18.98 | 2023-2024 | Nexplanon |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $14.69 | 2023 | Dexcom G6 Transmitter |
| Minerva Surgical, INC | $14.59 | 2024 | |
| Novo Nordisk INC | $13.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Ornelas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.